125 related articles for article (PubMed ID: 28100275)
21. Hypofolatemia as a risk factor for head and neck cancer.
Paludetti G; Almadori G; Bussu F; Galli J; Cadoni G; Maurizi M
Adv Otorhinolaryngol; 2005; 62():12-24. PubMed ID: 15608414
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
[TBL] [Abstract][Full Text] [Related]
23. PET monitoring of therapy response in head and neck squamous cell carcinoma.
Schöder H; Fury M; Lee N; Kraus D
J Nucl Med; 2009 May; 50 Suppl 1():74S-88S. PubMed ID: 19380408
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of SERPINB13 expression in head and neck squamous cell carcinomas associates with poor clinical outcome.
de Koning PJ; Bovenschen N; Leusink FK; Broekhuizen R; Quadir R; van Gemert JT; Hordijk GJ; Chang WS; van der Tweel I; Tilanus MG; Kummer JA
Int J Cancer; 2009 Oct; 125(7):1542-50. PubMed ID: 19569240
[TBL] [Abstract][Full Text] [Related]
25. Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas.
Hanken H; Gaudin R; Gröbe A; Fraederich M; Eichhorn W; Smeets R; Simon R; Sauter G; Grupp K; Izbicki JR; Sehner S; Heiland M; Blessmann M
J Oral Pathol Med; 2014 Apr; 43(4):304-8. PubMed ID: 24645976
[TBL] [Abstract][Full Text] [Related]
26. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
[TBL] [Abstract][Full Text] [Related]
27. The expression of activin receptor-like kinase 1 among patients with head and neck cancer.
Chien CY; Chuang HC; Chen CH; Fang FM; Chen WC; Huang CC; Huang HY
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):965-73. PubMed ID: 23447486
[TBL] [Abstract][Full Text] [Related]
28. SIRT1 expression is associated with good prognosis for head and neck squamous cell carcinoma patients.
Noguchi A; Li X; Kubota A; Kikuchi K; Kameda Y; Zheng H; Miyagi Y; Aoki I; Takano Y
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Mar; 115(3):385-92. PubMed ID: 23453030
[TBL] [Abstract][Full Text] [Related]
29. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
Hass HG; Schmidt A; Nehls O; Kaiser S
Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
[TBL] [Abstract][Full Text] [Related]
30. FDG uptake in primary squamous cell carcinoma of the head and neck. The relationship between overexpression of glucose transporters and hexokinases, tumour proliferation and apoptosis.
Deron P; Vangestel C; Goethals I; De Potter A; Peeters M; Vermeersch H; Van de Wiele C
Nuklearmedizin; 2011; 50(1):15-21. PubMed ID: 21052609
[TBL] [Abstract][Full Text] [Related]
31. Role of tumor cell senescence in non-professional phagocytosis and cell-in-cell structure formation.
Gottwald D; Putz F; Hohmann N; Büttner-Herold M; Hecht M; Fietkau R; Distel L
BMC Mol Cell Biol; 2020 Nov; 21(1):79. PubMed ID: 33160318
[TBL] [Abstract][Full Text] [Related]
32. Active Component of Antrodia cinnamomea Mycelia Targeting Head and Neck Cancer Initiating Cells through Exaggerated Autophagic Cell Death.
Chang CW; Chen CC; Wu MJ; Chen YS; Chen CC; Sheu SJ; Lin TW; Chou SH; Lin SC; Liu CJ; Lee TC; Huang CY; Lo JF
Evid Based Complement Alternat Med; 2013; 2013():946451. PubMed ID: 23843890
[TBL] [Abstract][Full Text] [Related]
33. Cell-in-cell structure in cancer: evading strategies from anti-cancer therapies.
Okuyama K; Fukushima H; Naruse T; Yanamoto S
Front Oncol; 2023; 13():1248097. PubMed ID: 37790755
[TBL] [Abstract][Full Text] [Related]
34. AIM-CICs: an automatic identification method for cell-in-cell structures based on convolutional neural network.
Tang M; Su Y; Zhao W; Niu Z; Ruan B; Li Q; Zheng Y; Wang C; Zhang B; Zhou F; Wang X; Huang H; Shi H; Sun Q
J Mol Cell Biol; 2022 Nov; 14(6):. PubMed ID: 35869978
[TBL] [Abstract][Full Text] [Related]
35. Subtype-Based Prognostic Analysis of Cell-in-Cell Structures in Early Breast Cancer.
Zhang X; Niu Z; Qin H; Fan J; Wang M; Zhang B; Zheng Y; Gao L; Chen Z; Tai Y; Yang M; Huang H; Sun Q
Front Oncol; 2019; 9():895. PubMed ID: 31681557
[TBL] [Abstract][Full Text] [Related]
36. Surface Lin28A expression consistent with cellular stress parallels indicators of senescence.
Broughton K; Esquer C; Echeagaray O; Firouzi F; Shain G; Ebeid D; Monsanto M; Yaareb D; Golgolab L; Gude N; Sussman MA
Cardiovasc Res; 2023 May; 119(3):743-758. PubMed ID: 35880724
[TBL] [Abstract][Full Text] [Related]
37. Detecting cell-in-cell structures in human tumor samples by E-cadherin/CD68/CD45 triple staining.
Huang H; Chen A; Wang T; Wang M; Ning X; He M; Hu Y; Yuan L; Li S; Wang Q; Liu H; Chen Z; Ren J; Sun Q
Oncotarget; 2015 Aug; 6(24):20278-87. PubMed ID: 26109430
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneity of tumor cells in terms of cancer-initiating cells.
Morii E
J Toxicol Pathol; 2017 Jan; 30(1):1-6. PubMed ID: 28190919
[TBL] [Abstract][Full Text] [Related]
39. Heterotypic cell-in-cell structures between cancer and NK cells are associated with enhanced anticancer drug resistance.
Choe YJ; Min JY; Lee H; Lee SY; Kwon J; Kim HJ; Lee J; Kim HM; Park HS; Cho MY; Hyun JY; Kim HM; Chung YH; Ha SK; Jeong HG; Choi I; Kim TD; Hong KS; Han EH
iScience; 2022 Sep; 25(9):105017. PubMed ID: 36105584
[TBL] [Abstract][Full Text] [Related]
40. Spelling Out CICs: A Multi-Organ Examination of the Contributions of Cancer Initiating Cells' Role in Tumor Progression.
Baisiwala S; Budhiraja S; Goel C; Nandoliya KR; Saathoff MR; Ahmed AU
Stem Cell Rev Rep; 2022 Jan; 18(1):228-240. PubMed ID: 34244971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
